Is C7A.1 a billable code?
Yes. C7A.1 is a billable ICD-10-CM code and can be used on claims and superbills for dates of service from October 1, 2026 to September 30, 2027.
ICD-10-CM FY2027 diagnosis code
C7A.1: Malignant poorly differentiated neuroendocrine tumors
Billable codeValid for dates of service October 1, 2026 to September 30, 2027
C7A.1 is a billable ICD-10-CM diagnosis code for malignant poorly differentiated neuroendocrine tumors. It is specific enough to use on an insurance claim, a superbill or a Good Faith Estimate.
Superbill GeneratorStart a superbill with C7A.1 already added.Good Faith EstimateStart a cost estimate with C7A.1 already added.CMS-1500 Claim FormFill a claim form with C7A.1 in box 21.
Other codes in C7A Malignant neuroendocrine tumors
C7A.1 questions
What does C7A.1 mean?
C7A.1 is the ICD-10-CM code for Malignant poorly differentiated neuroendocrine tumors. It is in chapter 2, Neoplasms (C00-D49).
Code titles come from the official ICD-10-CM files published by the CDC National Center for Health Statistics. Always check payer rules and the clinical record before billing.